Format

Send to

Choose Destination
J Pediatr. 2015 Aug;167(2):390-6.e3. doi: 10.1016/j.jpeds.2015.04.077. Epub 2015 Jun 6.

Quality of Life and Its Determinants in a Multicenter Cohort of Children with Alagille Syndrome.

Author information

1
The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada. Electronic address: binita.kamath@sickkids.ca.
2
University of Michigan, Ann Arbor, MI.
3
Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA.
4
Ann and Robert H. Lurie Children's Hospital and Northwestern University, Chicago, IL.
5
Mount Sinai Medical Center, New York City, NY.
6
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
7
Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
8
The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
9
Seattle Children's Hospital and the University of Washington School of Medicine, Seattle, WA.
10
University of California, San Francisco, CA.
11
Johns Hopkins Medical Institutions, Baltimore, MD.
12
Riley Hospital for Children, Indiana University, Indianapolis, IN.
13
Saint Louis University School of Medicine, St. Louis, MO.
14
Washington University, St. Louis, MO.
15
Children's Hospital Los Angeles, Los Angeles, CA.
16
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
17
University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.

Abstract

OBJECTIVES:

To assess health-related quality of life (HRQOL) in children with Alagille syndrome (ALGS) in comparison with healthy and other liver disease cohorts, and to identify determinants of HRQOL in patients with ALGS.

STUDY DESIGN:

Within the Childhood Liver Disease Research Network prospective study of cholestasis, Pediatric Quality of Life Inventory (PedsQL) questionnaires were administered to 70 children with ALGS, 95 children with alpha-1-antitrypsin deficiency (A1ATD), and 49 children with other causes of chronic intrahepatic cholestasis (IHC) aged 5-18 years. Parent proxy PedsQL scores were recorded for children aged 2-18 years (98 ALGS, 123 A1ATD, and 68 IHC).

RESULTS:

Mean ages and total bilirubin (mg/dL) were ALGS 9.4 years; 4.4, A1ATD 9.5 years; 0.7, and IHC 10.3 years; 2.9. ALGS child PedsQL scores were lower than in healthy children and children with A1ATD (mean 73 vs 83; P = .001). Children with ALGS and IHC were similar, except in physical scores (73 vs 79; P = .05). Parents of children with ALGS perceived their children to have worse HRQOL than A1ATD (P ≤ .001) and marginally lower compared with IHC. Univariate analysis revealed ALGS child-reported scores were positively associated with better growth and inversely with total bilirubin. Growth failure, elevated international normalized ratio, and an intracardiac defect were predictive of poor parental scores (P ≤ .05). In multivariate analysis, only weight z-score remained significant for child- and parent-reported scores.

CONCLUSIONS:

HRQOL is impaired in children with ALGS compared with healthy and children with A1ATD, similar to children with IHC and is associated with growth failure, which is a potentially treatable cause of impaired HRQOL.

PMID:
26059338
PMCID:
PMC4516587
DOI:
10.1016/j.jpeds.2015.04.077
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Grant support

Publication types

MeSH terms

Grant support

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center